Published On 5/11/2025
|
Last update: 13:11 (Mecca time)
The fall COVID-19 vaccine season has gotten off to a slow start for Pfizer, with U.S. sales of doses of its Commernaty vaccine falling 25% after federal regulators narrowed recommendations on who should get it.
The approval of the updated vaccines also came several weeks later than usual, and Pfizer said on Tuesday that this also hurt sales.
Many Americans get vaccines in the fall, to protect against any disease outbreak the following winter. Experts say that interest
COVID-19 vaccinations are declining, and that decline may increase this fall due to anti-vaccine sentiment and confusion about whether the shots are necessary.
The Centers for Disease Control and Prevention last month stopped recommending Covid-19 vaccines for anyone, instead leaving the choice to patients. She said that she adopts the recommendations presented by the advisors chosen by US Secretary of Health Robert F. Kennedy Jr.